87 related articles for article (PubMed ID: 18445521)
1. Intracellular accumulation and DNA damage persistence as determinants of human squamous cell carcinoma hypersensitivity to the novel camptothecin ST1968.
Pisano C; Zuco V; De Cesare M; Benedetti V; Vesci L; Foderà R; Bucci F; Aulicino C; Penco S; Carminati P; Zunino F
Eur J Cancer; 2008 Jun; 44(9):1332-40. PubMed ID: 18445521
[TBL] [Abstract][Full Text] [Related]
2. ATM- and ATR-mediated response to DNA damage induced by a novel camptothecin, ST1968.
Zuco V; Benedetti V; Zunino F
Cancer Lett; 2010 Jun; 292(2):186-96. PubMed ID: 20042274
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models.
Meco D; Di Francesco AM; Cusano G; Bucci F; Pierri F; Patriarca V; Torella AR; Pisano C; Riccardi R
Cancer Chemother Pharmacol; 2012 Dec; 70(6):811-22. PubMed ID: 23007316
[TBL] [Abstract][Full Text] [Related]
4. Preclinical profile of antitumor activity of a novel hydrophilic camptothecin, ST1968.
Pisano C; De Cesare M; Beretta GL; Zuco V; Pratesi G; Penco S; Vesci L; Foderà R; Ferrara FF; Guglielmi MB; Carminati P; Dallavalle S; Morini G; Merlini L; Orlandi A; Zunino F
Mol Cancer Ther; 2008 Jul; 7(7):2051-9. PubMed ID: 18645015
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ST1968 (namitecan) on a topotecan-resistant squamous cell carcinoma.
Zuco V; Supino R; Favini E; Tortoreto M; Cincinelli R; Croce AC; Bucci F; Pisano C; Zunino F
Biochem Pharmacol; 2010 Feb; 79(4):535-41. PubMed ID: 19765546
[TBL] [Abstract][Full Text] [Related]
6. Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin.
De Cesare M; Pratesi G; Perego P; Carenini N; Tinelli S; Merlini L; Penco S; Pisano C; Bucci F; Vesci L; Pace S; Capocasa F; Carminati P; Zunino F
Cancer Res; 2001 Oct; 61(19):7189-95. PubMed ID: 11585754
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Bax enhances antitumor activity of chemotherapeutic agents in human head and neck squamous cell carcinoma.
Guo B; Cao S; Tóth K; Azrak RG; Rustum YM
Clin Cancer Res; 2000 Feb; 6(2):718-24. PubMed ID: 10690558
[TBL] [Abstract][Full Text] [Related]
8. Preclinical efficacy of ST1976, a novel camptothecin analog of the 7-oxyiminomethyl series.
De Cesare M; Beretta GL; Tinelli S; Benedetti V; Pratesi G; Penco S; Dallavalle S; Merlini L; Pisano C; Carminati P; Zunino F
Biochem Pharmacol; 2007 Mar; 73(5):656-64. PubMed ID: 17169332
[TBL] [Abstract][Full Text] [Related]
9. Cellular bases of the antitumor activity of a 7-substituted camptothecin in hormone-refractory human prostate carcinoma models.
Zuco V; Supino R; De Cesare M; Carenini N; Perego P; Gatti L; Pratesi G; Pisano C; Martinelli R; Bucci F; Zanier R; Carminati P; Zunino F
Biochem Pharmacol; 2003 Apr; 65(8):1281-94. PubMed ID: 12694869
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies.
Caserini C; Pratesi G; Tortoreto M; Bedogné B; Carenini N; Supino R; Perego P; Righetti SC; Zunino F
Clin Cancer Res; 1997 Jun; 3(6):955-61. PubMed ID: 9815771
[TBL] [Abstract][Full Text] [Related]
11. A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts.
Supino R; Polizzi D; Pavesi R; Pratesi G; Guano F; Capranico G; Palumbo M; Sissi C; Richter S; Beggiolin G; Menta E; Pezzoni G; Spinelli S; Torriani D; Carenini N; Dal Bo L; Facchinetti F; Tortoreto M; Zunino F
Oncology; 2001; 61(3):234-42. PubMed ID: 11574780
[TBL] [Abstract][Full Text] [Related]
12. The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects.
Cassinelli G; Zuco V; Petrangolini G; De Cesare M; Tortoreto M; Lanzi C; Cominetti D; Zaffaroni N; Orlandi A; Passeri D; Meco D; Di Francesco AM; Riccardi R; Bucci F; Pisano C; Zunino F
Biochem Pharmacol; 2012 Jul; 84(2):163-71. PubMed ID: 22525722
[TBL] [Abstract][Full Text] [Related]
13. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks.
Smith LM; Willmore E; Austin CA; Curtin NJ
Clin Cancer Res; 2005 Dec; 11(23):8449-57. PubMed ID: 16322308
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic synergy between irinotecan and 5-fluorouracil against human tumor xenografts.
Azrak RG; Cao S; Slocum HK; Tóth K; Durrani FA; Yin MB; Pendyala L; Zhang W; McLeod HL; Rustum YM
Clin Cancer Res; 2004 Feb; 10(3):1121-9. PubMed ID: 14871992
[TBL] [Abstract][Full Text] [Related]
15. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.
Hu H; Jiang C; Ip C; Rustum YM; Lü J
Clin Cancer Res; 2005 Mar; 11(6):2379-88. PubMed ID: 15788689
[TBL] [Abstract][Full Text] [Related]
16. Nuclear caspase-3 and caspase-7 activation, and poly(ADP-ribose) polymerase cleavage are early events in camptothecin-induced apoptosis.
Rodríguez-Hernández A; Brea-Calvo G; Fernández-Ayala DJ; Cordero M; Navas P; Sánchez-Alcázar JA
Apoptosis; 2006 Jan; 11(1):131-9. PubMed ID: 16374543
[TBL] [Abstract][Full Text] [Related]
17. Luteolin induces apoptosis in oral squamous cancer cells.
Yang SF; Yang WE; Chang HR; Chu SC; Hsieh YS
J Dent Res; 2008 Apr; 87(4):401-6. PubMed ID: 18362328
[TBL] [Abstract][Full Text] [Related]
18. Rubitecan.
Clark JW
Expert Opin Investig Drugs; 2006 Jan; 15(1):71-9. PubMed ID: 16370935
[TBL] [Abstract][Full Text] [Related]
19. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo.
Gu X; Song X; Dong Y; Cai H; Walters E; Zhang R; Pang X; Xie T; Guo Y; Sridhar R; Califano JA
Clin Cancer Res; 2008 Mar; 14(6):1840-8. PubMed ID: 18347187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
